Drug:
Reaction: VISUAL IMPAIRMENT
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940182 |
CA |
68 | 1 |
Cataract, Eye haemorrhage, Visual impairment, |
||||
INFLIXIMAB, |
||||
| 2 | 26940343 |
US |
2 | |
Hospitalisation, Visual impairment, |
||||
ABALOPARATIDE, |
||||
| 3 | 26940345 |
US |
2 | |
Visual impairment, |
||||
ABALOPARATIDE, UPADACITINIB, ERGOCALCIFEROL, |
||||
| 4 | 26940685 |
US |
||
Keratomileusis, Visual impairment, Product dose omission issue, Corrective lens user, Wrong technique in product usage process, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 5 | 26940763 |
US |
2 | |
Hernia repair, Scar, Fear of injection, Allergy to chemicals, Otorrhoea, Visual impairment, Nasal congestion, Sinusitis, Hernia, Dyspepsia, Eczema, Dyspnoea, Dizziness, Blood pressure increased, Nausea, Palpitations, Blood calcium increased, Headache, Arthralgia, Incorrect dose administered, Product distribution issue, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CALCIUM, |
||||
| 6 | 26941253 |
US |
77 | 2 |
Retinal detachment, Fatigue, Off label use, Decreased appetite, Taste disorder, Alopecia, Eye swelling, Diplopia, Visual impairment, Lacrimation increased, Unevaluable event, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 7 | 26941278 |
US |
77 | 2 |
Hypoacusis, Memory impairment, Visual impairment, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 8 | 26941753 |
US |
2 | |
Confusional state, Visual impairment, Muscle disorder, Oral pain, Feeling abnormal, Headache, |
||||
ABALOPARATIDE, |
||||
| 9 | 26941914 |
ZA |
1 | |
Retinal thickening, Visual impairment, |
||||
FARICIMAB, FARICIMAB, |
||||
| 10 | 26941957 |
US |
2 | |
Mydriasis, Visual impairment, Gastrooesophageal reflux disease, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 11 | 26942072 |
US |
78 | 2 |
Cataract, Gait disturbance, Visual impairment, |
||||
LINACLOTIDE, |
||||
| 12 | 26942595 |
US |
34 | 2 |
Tunnel vision, Chills, Postural orthostatic tachycardia syndrome, Food aversion, Headache, Nausea, Vomiting, Visual impairment, |
||||
APREMILAST, |
||||
| 13 | 26942636 |
US |
85 | 2 |
Macular degeneration, Visual impairment, Product container issue, |
||||
CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, |
||||
| 14 | 26942867 |
US |
44 | 2 |
Visual impairment, |
||||
DUPILUMAB, |
||||
| 15 | 26942891 |
US |
55 | 1 |
Visual impairment, |
||||
BELANTAMAB MAFODOTIN, |
||||
| 16 | 26943102 |
ZA |
84 | 2 |
Optical coherence tomography abnormal, Retinal thickening, Visual impairment, |
||||
FARICIMAB, |
||||
| 17 | 26943662 |
ZA |
2 | |
Optical coherence tomography abnormal, Retinal thickening, Visual impairment, |
||||
FARICIMAB, FARICIMAB, |
||||
| 18 | 26943693 |
US |
36 | 1 |
Visual impairment, Photophobia, Vision blurred, Dizziness, Confusional state, Disorientation, Discontinued product administered, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 19 | 26943740 |
ZA |
2 | |
Retinal thickening, Off label use, Optical coherence tomography abnormal, Visual impairment, |
||||
FARICIMAB, FARICIMAB, |
||||
| 20 | 26943798 |
GB |
49 | 2 |
Visual impairment, Dizziness, Tinnitus, Head discomfort, Balance disorder, Fatigue, |
||||
TIRZEPATIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PROCHLORPERAZINE, |
||||
| 21 | 26943925 |
CA |
53 | 2 |
Visual impairment, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 22 | 26944023 |
CA |
74 | 2 |
Death, Pneumonia, Cardiac failure, Malaise, Peripheral swelling, Erythema, Arthralgia, Visual impairment, Gastroenteritis, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, |
||||
| 23 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 24 | 26944500 |
US |
68 | 1 |
Visual impairment, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 25 | 26944517 |
KR |
67 | 2 |
Xerophthalmia, Visual impairment, |
||||
EZETIMIBE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 26 | 26944522 |
US |
2 | |
Visual impairment, Product dose omission in error, Wrong technique in product usage process, Product closure removal difficult, |
||||
LATANOPROST, TIMOLOL, |
||||
| 27 | 26944705 |
US |
72 | 2 |
Dry mouth, Fatigue, Dry eye, Visual impairment, |
||||
SPARSENTAN, SPARSENTAN, AMLODIPINE, |
||||
| 28 | 26944770 |
US |
2 | |
Visual impairment, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 29 | 26944845 |
US |
60 | 2 |
Aortic arteriosclerosis, Blood cholesterol abnormal, Low density lipoprotein abnormal, Lipoprotein (a) abnormal, Fatigue, Abnormal dreams, Asthenia, Visual impairment, Poor quality sleep, |
||||
EVOLOCUMAB, EZETIMIBE, |
||||
| 30 | 26944952 |
US |
61 | 2 |
Hearing disability, Visual impairment, Plantar fasciitis, Nausea, Fatigue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, FISH OIL, FAMOTIDINE, ZINC SULFATE, ZINC SULFATE INJECTION,, ZINC SULFATE INJECTION, |
||||
| 31 | 26945145 |
US |
1 | |
Visual impairment, |
||||
ABALOPARATIDE, |
||||
| 32 | 26945215 |
US |
77 | 2 |
Visual impairment, Chest pain, Stress, Nausea, Headache, Dyspnoea, Blood pressure increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, NEBIVOLOL HYDROCHLORIDE, |
||||
| 33 | 26945351 |
US |
71 | 2 |
Fatigue, Temperature intolerance, Photophobia, Visual impairment, Thyroid mass, Thyroid cancer, |
||||
PEMBROLIZUMAB, |
||||
| 34 | 26945612 |
US |
61 | 2 |
Visual impairment, Arthralgia, Palpitations, |
||||
ABALOPARATIDE, ROPINIROLE, |
||||
| 35 | 26945860 |
US |
2 | |
Nausea, Vomiting, Oropharyngeal pain, Fatigue, Visual impairment, Transient ischaemic attack, Feeling abnormal, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 36 | 26946085 |
US |
66 | 2 |
Hypoglycaemia, Visual impairment, Muscular weakness, Muscle contractions involuntary, Migraine, Memory impairment, Eyelid ptosis, Dyspnoea, Neck pain, Headache, Heart rate increased, Injection site pain, Injection site bruising, Bone pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, MUPIROCIN, MUPIROCIN CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FEXOFENADINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ONABOTULINUMTOXINA, ONDANSETRON HYDROCHLORIDE, MELATONIN, ZOLPIDEM TARTRATE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, CARISOPRODOL, GABAPENTIN, FAMOTIDINE, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 37 | 26946101 |
US |
2 | |
Dry eye, Eye swelling, Eye pruritus, Rhinorrhoea, Sinus pain, Visual impairment, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ETANERCEPT, |
||||
| 38 | 26946271 |
US |
57 | 2 |
Visual impairment, Drug delivery system issue, Drug dose omission by device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 39 | 26946347 |
US |
2 | |
Visual impairment, Injection site pain, Headache, Insomnia, Fatigue, Bone pain, Pain, Drug hypersensitivity, Product dose omission in error, Device defective, Device physical property issue, Drug dose omission by device, Needle issue, Product communication issue, Injury associated with device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 40 | 26946392 |
EU |
70 | 1 |
Ulcerative keratitis, Visual impairment, Surgery, |
||||
PEMBROLIZUMAB, |
||||
| 41 | 26946776 |
US |
2 | |
Mood altered, Anxiety, Vision blurred, Visual impairment, Condition aggravated, Panic attack, Nausea, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 42 | 26947147 |
US |
2 | |
Vision blurred, Visual impairment, |
||||
MIRVETUXIMAB SORAVTANSINE, |
||||
| 43 | 26947671 |
US |
95 | 1 |
Visual impairment, Blood pressure decreased, Chest pain, Adverse drug reaction, |
||||
ABALOPARATIDE, |
||||
| 44 | 26947848 |
US |
||
Burning sensation, Abnormal sensation in eye, Dry eye, Migraine, Nausea, Visual impairment, |
||||
PERFLUOROHEXYLOCTANE, |
||||
| 45 | 26948192 |
US |
2 | |
Gait disturbance, Visual impairment, Hypoacusis, Cystitis, Diarrhoea, Fatigue, Abdominal pain upper, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 46 | 26948196 |
US |
72 | 2 |
Neck pain, Visual impairment, Eye pain, Pain in jaw, Headache, Arthralgia, Back pain, |
||||
ABALOPARATIDE, |
||||
| 47 | 26948229 |
BR |
61 | 2 |
Blood glucose increased, Cataract, Visual impairment, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 48 | 26948240 |
2 | ||
Ankle fracture, Fall, Tibia fracture, Blood glucose increased, Keloid scar, Injection site mass, Visual impairment, Hypoglycaemia, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN LISPRO, |
||||
| 49 | 26948259 |
US |
2 | |
Visual impairment, Rash morbilliform, Seborrhoea, Dizziness, |
||||
ABALOPARATIDE, ABALOPARATIDE, LORAZEPAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ESCITALOPRAM, ONDANSETRON HYDROCHLORIDE, |
||||
| 50 | 26948279 |
US |
56 | 2 |
Visual impairment, Hypersomnia, Food craving, Feeding disorder, Visual impairment, Photopsia, Myalgia, Bedridden, Unevaluable event, Joint swelling, Injection site erythema, Injection site pain, Abdominal pain upper, Headache, Injection site bruising, Illness, Fatigue, Nausea, Vomiting, Dizziness, Arthralgia, Lethargy, Asthenia, Abdominal pain, Product storage issue, Product storage issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, BUPROPION, GLYCERIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PEPPERMINT OIL, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 51 | 26951159 |
67 | 2 | |
Joint swelling, Fatigue, Dizziness, Visual impairment, Abdominal distension, |
||||
DUPILUMAB, |
||||
| 52 | 26952533 |
83 | 2 | |
Visual impairment, Cataract, |
||||
TRETINOIN, FLUTICASONE PROPIONATE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 53 | 26934247 |
US |
2 | |
Craniocerebral injury, Incorrect dose administered, Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 54 | 26934312 |
US |
79 | 2 |
Visual impairment, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 55 | 26934444 |
US |
2 | |
Visual impairment, Product use complaint, Circumstance or information capable of leading to medication error, Product container issue, Product label issue, |
||||
LATANOPROST, |
||||
| 56 | 26935247 |
ZA |
61 | 2 |
Off label use, Optical coherence tomography abnormal, Visual impairment, Retinal thickening, |
||||
FARICIMAB, |
||||
| 57 | 26935488 |
ZA |
1 | |
Retinal thickening, Visual impairment, |
||||
FARICIMAB, |
||||
| 58 | 26935767 |
CA |
43 | 2 |
C-reactive protein, Lip dry, Therapeutic product effect incomplete, Liver injury, Drug hypersensitivity, Adverse drug reaction, Normal newborn, Joint swelling, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hypercholesterolaemia, Exposure during pregnancy, Glossodynia, Duodenal ulcer perforation, Systemic lupus erythematosus, Confusional state, Contraindicated product administered, Oedema, General physical health deterioration, Blister, Musculoskeletal stiffness, Pericarditis, Hip arthroplasty, Anxiety, Deep vein thrombosis postoperative, Joint range of motion decreased, Pregnancy, Malaise, Chest pain, Abdominal discomfort, Hepatic enzyme increased, Decreased appetite, Nausea, Arthralgia, Hypoaesthesia, Fibromyalgia, Sleep disorder due to general medical condition, insomnia type, Red blood cell sedimentation rate increased, Rheumatic fever, Injury, Pain, Pain in extremity, Paraesthesia, Helicobacter infection, Type 2 diabetes mellitus, Visual impairment, Arthropathy, Gastrointestinal disorder, Infusion related reaction, Osteoarthritis, Retinitis, Irritable bowel syndrome, Pemphigus, Insomnia, Knee arthroplasty, Inflammation, Headache, Fatigue, Autoimmune disorder, Maternal exposure during pregnancy, Intentional product misuse, Oedema peripheral, Wound, Asthma, Drug intolerance, Infection, Rheumatoid factor positive, Asthenia, Discomfort, Treatment failure, Grip strength decreased, Intentional product use issue, C-reactive protein increased, Contusion, Diarrhoea, Arthritis, Rheumatoid arthritis, Rash, Hypertension, Blood cholesterol increased, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB CITRATE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB, VITAMIN C, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, APREMILAST, APREMILAST, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, APREMILAST, APREMILAST, APREMILAST, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, ABATACEPT, ABATACEPT, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ERENUMAB-AOOE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, ERGOCALCIFEROL, LISINOPRIL, CAFFEINE CITRATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 59 | 26935910 |
CA |
2 | |
Hallucination, Weight decreased, Haemoglobin decreased, Visual impairment, Musculoskeletal stiffness, Hypersensitivity, Drug ineffective, |
||||
PREDNISONE, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, FUROSEMIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, PYRIDOSTIGMINE BROMIDE, ALBUTEROL SULFATE, AZATHIOPRINE, RAMIPRIL, ROSUVASTATIN CALCIUM, HUMAN IMMUNOGLOBULIN G, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 60 | 26935941 |
19 | 2 | |
Blindness, Visual impairment, |
||||
MOMETASONE, |
||||
| 61 | 26936108 |
EU |
43 | |
Visual impairment, Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, PRAMIPEXOLE, |
||||
| 62 | 26936211 |
US |
1 | |
Visual impairment, |
||||
DIROXIMEL FUMARATE, |
||||
| 63 | 26936269 |
US |
64 | 2 |
Visual impairment, |
||||
INSULIN HUMAN, |
||||
| 64 | 26936356 |
US |
67 | 2 |
Asthenopia, Dry skin, Skin exfoliation, Skin fissures, Skin hyperpigmentation, Visual impairment, Erythema, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 65 | 26936428 |
CA |
2 | |
Pancreatitis, Pruritus, Intentional product use issue, Drug tolerance decreased, Lower limb fracture, Joint dislocation, Hypoaesthesia, Therapeutic product effect decreased, Treatment failure, Dyspepsia, Swollen joint count increased, Foot deformity, Ear infection, Mobility decreased, Visual impairment, Sciatica, Porphyria acute, Injury, Colitis ulcerative, Osteoporosis, Contraindicated product administered, Incorrect route of product administration, Hypersensitivity, Bronchitis, Facet joint syndrome, Infection, Spondylitis, Drug-induced liver injury, Maternal exposure during pregnancy, Product quality issue, Seronegative arthritis, C-reactive protein, Nasopharyngitis, Migraine, Rheumatic fever, Therapy non-responder, Malaise, Retinitis, Prescribed overdose, Road traffic accident, Drug ineffective, Frequent bowel movements, |
||||
ERENUMAB-AOOE, ETANERCEPT, APREMILAST, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, PREDNISONE, PREDNISONE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CELECOXIB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LANSOPRAZOLE, LANSOPRAZOLE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, OXYCODONE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, GOLIMUMAB, TRAMADOL HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROMORPHONE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, LEFLUNOMIDE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, CAFFEINE CITRATE, ICOSAPENT ETHYL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RISEDRONATE SODIUM, SULFASALAZINE, |
||||
| 66 | 26936547 |
US |
1 | |
Memory impairment, Mobility decreased, Visual impairment, Device use error, Product dose omission issue, Wrong technique in product usage process performed in error, Product complaint, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 67 | 26936585 |
US |
2 | |
Product storage issue, Visual impairment, Expired product administered, |
||||
ORAL SEMAGLUTIDE, |
||||
| 68 | 26936618 |
US |
2 | |
Brain oedema, Neuroleptic malignant syndrome, Speech disorder, Visual impairment, Blood pressure abnormal, Dysstasia, Ear disorder, Sinusitis, Parkinsonism, Thinking abnormal, Gait disturbance, Paraesthesia, Tremor, Throat tightness, Oropharyngeal swelling, Product use in unapproved indication, |
||||
ILOPERIDONE, LISINOPRIL, |
||||
| 69 | 26936969 |
CA |
59 | 2 |
Asthma, Blood cholesterol increased, Hypercholesterolaemia, Swelling, Nasopharyngitis, Liver injury, Duodenal ulcer perforation, Off label use, Anti-cyclic citrullinated peptide antibody positive, Injury, Diarrhoea, Hypertension, Swollen joint count increased, Helicobacter infection, Psoriatic arthropathy, Adverse event, Tachycardia, Fibromyalgia, Arthropathy, Rheumatic fever, Type 2 diabetes mellitus, Bronchitis, Blister, Upper respiratory tract infection, Therapeutic product effect decreased, Visual impairment, Pericarditis, Lupus vulgaris, Pain, Retinitis, Wound, Therapeutic product effect incomplete, Oedema peripheral, Musculoskeletal stiffness, Product use issue, Pemphigus, Contraindicated product administered, Rheumatoid arthritis, Red blood cell sedimentation rate increased, Rheumatoid factor positive, Pain in extremity, Anxiety, Systemic lupus erythematosus, Intentional product use issue, Rash, Treatment failure, Exposure during pregnancy, Drug ineffective, Product use in unapproved indication, Maternal exposure during pregnancy, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, QUETIAPINE FUMARATE, QUETIAPINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PHENYLEPHRINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ERGOCALCIFEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, MINOCYCLINE HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISONE, PREDNISONE, PREDNISONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SECUKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, CALCIUM CARBONATE, CALCIUM CARBONATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB CITRATE, DESOXIMETASONE, VITAMIN C, VITAMIN C, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, AZATHIOPRINE, PANTOPRAZOLE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, RAMIPRIL, USTEKINUMAB, USTEKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LANSOPRAZOLE, PANTOPRAZOLE, TOFACITINIB, TOFACITINIB, QUETIAPINE FUMARATE, QUETIAPINE, HYDROMORPHONE HYDROCHLORIDE, LISINOPRIL, LISINOPRIL, BUPROPION HYDROCHLORIDE, |
||||
| 70 | 26937265 |
74 | ||
Syncope, Temperature intolerance, Visual impairment, Dehydration, Glucose tolerance impaired, Contusion, Hypercholesterolaemia, Blood bilirubin increased, Hypertension, Hyporeflexia, Blood immunoglobulin E, Hypotension, Hypertonic bladder, Large intestine polyp, Arthropathy, Bradycardia, Cholelithiasis, Intentional product use issue, Treatment noncompliance, |
||||
PALTUSOTINE, PALTUSOTINE, PALTUSOTINE, ROSUVASTATIN, |
||||
| 71 | 26937281 |
US |
2 | |
Visual impairment, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 72 | 26937775 |
US |
2 | |
Visual impairment, Confusional state, Unintentional use for unapproved indication, |
||||
PIMAVANSERIN TARTRATE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BENZTROPINE, FENOFIBRATE, ESCITALOPRAM, LOVASTATIN, PREGABALIN, BUPROPION HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, |
||||
| 73 | 26938159 |
US |
1 | |
Visual impairment, Off label use, |
||||
EVOLOCUMAB, |
||||
| 74 | 26938186 |
US |
82 | 1 |
Visual impairment, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 75 | 26938211 |
RU |
1 | |
Pulmonary fibrosis, Scar discomfort, Visual impairment, Palmoplantar keratoderma, Papilloma, Hepatomegaly, Hepatic steatosis, Lymphadenopathy, Lipogranuloma, Pulmonary calcification, Procedural site reaction, Liver disorder, Gallbladder disorder, Pancreatic disorder, Renal disorder, Localised oedema, Cerebral microangiopathy, Pancreatic steatosis, |
||||
DABRAFENIB, DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, TRAMETINIB, |
||||
| 76 | 26938645 |
US |
68 | 1 |
Visual impairment, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 77 | 26938684 |
EU |
1 | |
Optic ischaemic neuropathy, Retinal detachment, Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 78 | 26938737 |
US |
2 | |
Visual impairment, Incorrect product administration duration, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 79 | 26939036 |
US |
1 | |
Visual impairment, |
||||
ABALOPARATIDE, |
||||
| 80 | 26939126 |
US |
2 | |
Visual impairment, |
||||
ABALOPARATIDE, |
||||
| 81 | 26939483 |
US |
2 | |
Nausea, Visual impairment, |
||||
ABALOPARATIDE, ABALOPARATIDE, CERTOLIZUMAB PEGOL, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROCHLOROTHIAZIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, ERGOCALCIFEROL, ZOLPIDEM TARTRATE, |
||||
| 82 | 26939616 |
US |
74 | 2 |
Visual impairment, Drug dose omission by device, Device difficult to use, Inappropriate schedule of product administration, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 83 | 26939640 |
US |
2 | |
COVID-19, Visual impairment, Fatigue, Product administered at inappropriate site, Product dose omission issue, Product administration error, Product preparation error, Incorrect disposal of product, Device issue, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 84 | 26939678 |
US |
2 | |
Visual impairment, Fatigue, Back pain, Headache, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 85 | 26931528 |
US |
70 | 2 |
Tremor, Muscular weakness, Urinary tract infection, Fatigue, Visual impairment, Vision blurred, |
||||
NIPOCALIMAB-AAHU, |
||||
| 86 | 26931578 |
US |
74 | 2 |
Visual impairment, Extra dose administered, |
||||
TIRZEPATIDE, |
||||
| 87 | 26931622 |
US |
2 | |
Visual impairment, |
||||
DUPILUMAB, |
||||
| 88 | 26931762 |
US |
2 | |
Visual impairment, Burning sensation, |
||||
DUPILUMAB, |
||||
| 89 | 26931848 |
US |
||
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 90 | 26931943 |
63 | ||
Visual impairment, |
||||
PALTUSOTINE, PALTUSOTINE, |
||||
| 91 | 26932386 |
US |
60 | 2 |
Visual impairment, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 92 | 26932933 |
80 | ||
Visual impairment, Asthenia, Intraocular pressure increased, Blood pressure increased, |
||||
METOPROLOL TARTRATE, AMLODIPINE BESYLATE, LOSARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLOPIDOGREL, |
||||
| 93 | 26932997 |
GB |
67 | 1 |
Visual impairment, |
||||
DOXAZOSIN MESYLATE, AMLODIPINE, AMLODIPINE, LANSOPRAZOLE, RAMIPRIL, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 94 | 26933087 |
AU |
42 | 2 |
Abortion spontaneous, Tunnel vision, Urinary retention, Blood prolactin increased, Constipation, Disturbance in attention, Dyspnoea, Fatigue, Heavy menstrual bleeding, Hot flush, Hyperarousal, Hypoacusis, Insomnia, Oedema, Pain, Restlessness, Visual impairment, Weight increased, Maternal exposure during pregnancy, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 95 | 26933128 |
US |
56 | 2 |
Visual impairment, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 96 | 26933298 |
US |
73 | 2 |
Visual impairment, Dry skin, Skin fissures, Pruritus, Dry eye, Eye irritation, |
||||
DUPILUMAB, |
||||
| 97 | 26933516 |
US |
63 | 1 |
Visual impairment, Vitreous floaters, Photopsia, Dry eye, Photophobia, Asthma, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 98 | 26933594 |
GB |
||
Visual impairment, Chills, Tremor, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 99 | 26926819 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Therapeutic product effect incomplete, Upper respiratory tract infection, Vasculitis, Visual impairment, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, RANIBIZUMAB, RANIBIZUMAB, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 100 | 26927264 |
US |
68 | 2 |
Dermatitis allergic, Erythema, Skin exfoliation, Dry eye, Visual acuity reduced, Visual impairment, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30